BU is a partner of The Conversation, a news analysis and opinion website with content written by academics working with professional journalists.
As a partner organisation, our academics and researchers can write for The Conversation on their areas of expertise. Conversation journalists are offering one-to-one training sessions for BU academics to understand more about The Conversation, or to discuss and pitch an article to them.
Two training dates are available, on Wednesday 28 February from 2–4pm or Tuesday 19 March from 10:30am – 12:30pm.
You can book a fifteen minute session with a Conversation journalist using the links below:
Book your place for 28 February
Why write for The Conversation?
The Conversation is a great way to share research and informed comment on topical issues. Academics work with editors to write pieces, which can then be republished via a Creative Commons licence. Since we first partnered with The Conversation, articles by BU authors have had over 9.5 million reads and been republished by the likes of The i, Metro, National Geographic Indonesia and the Washington Post.
You can learn more about working with The Conversation on the Research and Knowledge Exchange Sharepoint site.
The Conversation launches new online, on-demand training courses










Official book launch at Bournemouth University
Take a Break: Join the Creative Wellbeing Event
Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Three Minute Thesis (3MT®) 2026: Register to Support our PGRs
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease